Cancer stories

New Zealand's employee health plan costs are set to surge 18% in 2026, far exceeding the Asia Pacific and global averages amid rising healthcare demands.

RISA Labs has raised USD $3.5 million to advance its AI-driven platform, aiming to cut delays in cancer care by automating prior authorisations across 100 centres.

Volpara Health is using AI for breast cancer detection, enhancing screening accuracy and improving outcomes for millions globally.

SeqOIA, a key French genomics lab, adopts Scality RING to handle petabyte-scale genetic data, enhancing cancer and rare disease patient outcomes.

Two Google Cloud experts from Appsbroker CTS abseiled 27 floors in Amsterdam, raising EUR €2,105 for the Make-A-Wish Foundation at Google's Rope for Hope.

A revolutionary AI application uses sound data to detect laryngeal cancer with 80% accuracy, marking a breakthrough in cancer diagnosis tech.

Dr Mary Lou Jepsen, Chairman of Openwater, reveals how the company's technology could revolutionise cancer treatment.

Dell Technologies director, James Arnold, prepares for a stem cell transplant amidst his battle with Mantle Cell Lymphoma.

Let's hope that more of us are inspired to encourage the researchers who will face life-long challenges to unwrap the mysteries surrounding cancer.

Telecommunications stalwart Malcolm Benjamin, who lost his battle with cancer on Saturday, is being remembered as a loyal, genuine 'true gentleman'.

Vaughan Nankivell is being remembered as a man who threw himself into life and was passionate about all he did.

GlycoSyn is seeking new global customers for kifunensine, a key ingredient in the manufacture of a drug for the treatment of rare genetic disorders.

The largest study of its kind has found no link between childhood cancer and cellphone mast exposure during pregnancy.

A 10-year study involving 13 countries, including New Zealand, into possible links between cellphone use and cancer will be published next week.